inositol has been researched along with Metabolic Diseases in 13 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Several studies have evaluated the effect of inositol supplementation on lipid profiles among population with metabolic diseases; however, the findings are controversial." | 8.98 | The effects of inositol supplementation on lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials. ( Akbari, M; Asemi, Z; Kolahdooz, F; Lankarani, KB; Ostadmohammadi, V; Peymani, P; Tabrizi, R, 2018) |
| "Several studies have evaluated the effect of inositol supplementation on lipid profiles among population with metabolic diseases; however, the findings are controversial." | 4.98 | The effects of inositol supplementation on lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials. ( Akbari, M; Asemi, Z; Kolahdooz, F; Lankarani, KB; Ostadmohammadi, V; Peymani, P; Tabrizi, R, 2018) |
| "Insulin resistance is becoming an increasingly studied target for therapy, most evidence stemming from the time-honored metformin use." | 2.66 | Current treatment for polycystic ovary syndrome: focus on adolescence. ( Catellani, C; Cirillo, F; Dauriz, M; Lazzeroni, P; Moghetti, P; Sartori, C; Street, ME, 2020) |
| "Inositol deregulation has been found in a number of conditions mechanistically and epidemiologically associated to high-glucose diets or altered glucose metabolism." | 2.55 | Nutritional and Acquired Deficiencies in Inositol Bioavailability. Correlations with Metabolic Disorders. ( Bizzarri, M; Cucina, A; Dinicola, S; Minini, M; Unfer, V; Verna, R, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Street, ME | 1 |
| Cirillo, F | 1 |
| Catellani, C | 1 |
| Dauriz, M | 1 |
| Lazzeroni, P | 1 |
| Sartori, C | 1 |
| Moghetti, P | 1 |
| De Diego, MV | 1 |
| Gómez-Pardo, O | 1 |
| Groar, JK | 1 |
| López-Escobar, A | 1 |
| Martín-Estal, I | 1 |
| Castilla-Cortázar, I | 1 |
| Rodríguez-Zambrano, MÁ | 1 |
| Morgante, G | 1 |
| Massaro, MG | 1 |
| Di Sabatino, A | 1 |
| Cappelli, V | 1 |
| De Leo, V | 1 |
| Dinicola, S | 1 |
| Minini, M | 1 |
| Unfer, V | 1 |
| Verna, R | 1 |
| Cucina, A | 1 |
| Bizzarri, M | 1 |
| Tabrizi, R | 1 |
| Ostadmohammadi, V | 1 |
| Lankarani, KB | 1 |
| Peymani, P | 1 |
| Akbari, M | 1 |
| Kolahdooz, F | 1 |
| Asemi, Z | 1 |
| Ge, X | 1 |
| Xu, XY | 1 |
| Feng, CH | 1 |
| Wang, Y | 1 |
| Li, YL | 1 |
| Feng, B | 1 |
| Odinak, MM | 1 |
| Ianishevskiĭ, SN | 1 |
| Tsygan, NV | 1 |
| Golokhvastov, SIu | 1 |
| Vozniuk, IA | 1 |
| Trufanov, AG | 1 |
| Rodrigues, AC | 1 |
| Ferraz-Filho, JR | 1 |
| Torres, US | 1 |
| da Rocha, AJ | 1 |
| Muniz, MP | 1 |
| Souza, AS | 1 |
| Goloni-Bertollo, EM | 1 |
| Pavarino, ÉC | 1 |
| Napoli, C | 1 |
| Sessa, M | 1 |
| Infante, T | 1 |
| Casamassimi, A | 1 |
| LEVY, M | 1 |
| BECKMANN, R | 1 |
| Levine, J | 1 |
| Grisaru, N | 1 |
| Vetter, K | 1 |
| Täufel, K | 1 |
6 reviews available for inositol and Metabolic Diseases
| Article | Year |
|---|---|
Current treatment for polycystic ovary syndrome: focus on adolescence.
Topics: Adolescent; Contraceptives, Oral, Hormonal; Female; Gene-Environment Interaction; Humans; Hypoglycem | 2020 |
Therapeutic approach for metabolic disorders and infertility in women with PCOS.
Topics: Androgen Antagonists; Anovulation; Clomiphene; Contraceptives, Oral, Hormonal; Female; Gonadotropins | 2018 |
Nutritional and Acquired Deficiencies in Inositol Bioavailability. Correlations with Metabolic Disorders.
Topics: Biological Availability; Humans; Inositol; Metabolic Diseases; Nutritional Status | 2017 |
The effects of inositol supplementation on lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials.
Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Dietary Supplements; Female; Humans; Inositol; Lipid Meta | 2018 |
Unraveling framework of the ancestral Mediator complex in human diseases.
Topics: Animals; Cardiovascular Diseases; Catechols; Humans; Inositol; Mediator Complex; Metabolic Diseases; | 2012 |
[Inositol treatment in medicine].
Topics: Animals; Humans; Inositol; Inositol Phosphates; Mental Disorders; Metabolic Diseases; Models, Biolog | 1996 |
1 trial available for inositol and Metabolic Diseases
| Article | Year |
|---|---|
[The use of succinates for the correction of metabolic disorders in the penumbra in patients with stroke].
Topics: Adult; Aged; Aged, 80 and over; Antioxidants; Brain; Glucose; Humans; Inositol; Lactates; Magnetic R | 2013 |
6 other studies available for inositol and Metabolic Diseases
| Article | Year |
|---|---|
Metabolic impact of current therapeutic strategies in Polycystic Ovary Syndrome: a preliminary study.
Topics: Adolescent; Adult; Blood Glucose; Contraceptives, Oral, Combined; Female; Glycated Hemoglobin; Human | 2020 |
Relationships among serum C-reactive protein, receptor for advanced glycation products, metabolic dysfunction, and cognitive impairments.
Topics: Adult; Aged; Aspartic Acid; C-Reactive Protein; Cholesterol; Choline; Cognition Disorders; Female; H | 2013 |
Is magnetic resonance spectroscopy capable of detecting metabolic abnormalities in neurofibromatosis type 1 that are not revealed in brain parenchyma of normal appearance?
Topics: Adolescent; Aspartic Acid; Brain; Case-Control Studies; Child; Child, Preschool; Choline; Creatine; | 2015 |
[Effect of choline and inositol on metabolic disorders found in animals with various types of steatosis].
Topics: Animals; Choline; Fatty Liver; Inositol; Metabolic Diseases | 1957 |
[PATHOGENIC ELEMENTS AND THERAPEUTIC EXPERIENCES CONCERNING ERB'S PROGRESSIVE MUSCULAR DYSTROPHY].
Topics: Adenosine Triphosphate; Albumins; Ascorbic Acid; Calcium, Dietary; Choline; Diet; Diet Therapy; Frui | 1964 |
[Cereals in dietetics].
Topics: Calcium, Dietary; Carbohydrates; Diet; Diet Therapy; Edible Grain; Humans; Inositol; Intestinal Abso | 1971 |